Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56

B Drexler, A Tzankov, M Martinez… - International Journal …, 2021 - Wiley Online Library
Introduction CD56 is aberrantly expressed in myeloid neoplasms including myelodysplastic
syndrome (MDS) and acute myeloid leukemia (AML). Considering the adhesion effects of …
被引用次数：1 相关文章

Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.

B Drexler, A Tzankov, M Martinez… - International …, 2021 - search.ebscohost.com
Introduction: CD56 is aberrantly expressed in myeloid neoplasms including myelodysplastic
syndrome (MDS) and acute myeloid leukemia (AML). Considering the adhesion effects of …

Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56

B Drexler, A Tzankov, M Martinez… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction CD56 is aberrantly expressed in myeloid neoplasms including myelodysplastic
syndrome (MDS) and acute myeloid leukemia (AML). Considering the adhesion effects of …

Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.

B Drexler, A Tzankov, M Martinez… - … Journal of Laboratory …, 2021 - europepmc.org
Methods We retrospectively analyzed 75 patients diagnosed with MDS and AML. We
compared patients with (n= 36) and without (n= 39) CD56-expression by flow cytometry with …